Ding Yan, Zhao Lei, Mei Hong, Zhang Shu-Ling, Huang Zhi-Hua, Duan Yan-Ying, Ye Pian
Department of Gastroenterology and Hepatology, Medical and Health Center for Women and Children, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430016, PR China.
Eur J Pharmacol. 2008 Aug 20;590(1-3):377-86. doi: 10.1016/j.ejphar.2008.06.044. Epub 2008 Jun 17.
Emodin, 1,3,8-trihydroxy-6-methyl-anthraquinone, is an anthraquinone derivative from the roots of Rheum officinale Baill that has been used to treat many diseases in digestive system for thousands of years. This study is to disclose the mechanism of Emodin to treat cholestatic hepatitis via anti-inflammatory pathway. Rats were divided into Emodin, ursodeoxycholic acid, Dexamethasone, model and blank control groups with treatment of respective agent after administration of alpha-naphthylisothiocyanate. At 24 h, 48 h and 72 h time points after administration, liver function, pathological changes of hepatic tissue, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, myeloperoxidase (MPO), malondialdehyde (MDA), superoxide dismutase (SOD), cytokine-induced neutrophil chemoattractant (CINC)-1, macrophage inflammatory protein (MIP)-2, intercellular adhesion molecule (ICAM)-1, nuclear factor (NF)-kappaB and early growth response (Egr)-1, nitric oxide (NO) and inducible nitric oxide synthase (iNOS) were detected. As a result, compared to the controls, Emodin had a notable effect on rat's living condition, pathological manifestation of hepatic tissue, total bilirubin, direct bilirubin, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P<0.05), but had little effect on alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT) and total bile acid. With Emodin intervention, levels of TNF-alpha, IL-6, MPO, MDA, CINC-1, MIP-2, ICAM-1 and translocation of NF-kappaB were remarkably decreased, and levels of NO and iNOS were markedly increased (P<0.05). Emodin had no effect on Egr-1. In conclusion, Emodin has a protective effect on hepatocytes and a restoring activity on cholestatic hepatitis by anti-inflammation. The effects are mainly due to antagonizing pro-inflammatory cytokines and mediators, inhibiting oxidative damage, improving hepatic microcirculation, reducing impairment signals, and controlling neutrophil infiltration.
大黄素,即1,3,8-三羟基-6-甲基蒽醌,是一种从掌叶大黄根部提取的蒽醌衍生物,数千年来一直被用于治疗消化系统的多种疾病。本研究旨在揭示大黄素通过抗炎途径治疗胆汁淤积性肝炎的机制。将大鼠分为大黄素组、熊去氧胆酸组、地塞米松组、模型组和空白对照组,在给予α-萘异硫氰酸酯后分别给予相应药物治疗。给药后24小时、48小时和72小时时间点,检测肝功能、肝组织病理变化、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、髓过氧化物酶(MPO)、丙二醛(MDA)、超氧化物歧化酶(SOD)、细胞因子诱导的中性粒细胞趋化因子(CINC)-1、巨噬细胞炎性蛋白(MIP)-2、细胞间黏附分子(ICAM)-1、核因子(NF)-κB和早期生长反应(Egr)-1、一氧化氮(NO)和诱导型一氧化氮合酶(iNOS)。结果显示,与对照组相比,大黄素对大鼠的生存状况、肝组织病理表现、总胆红素、直接胆红素、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)有显著影响(P<0.05),但对碱性磷酸酶(ALP)、γ-谷氨酰转移酶(GGT)和总胆汁酸影响较小。经大黄素干预后,TNF-α、IL-6、MPO、MDA、CINC-1、MIP-2、ICAM-1水平及NF-κB转位显著降低,NO和iNOS水平显著升高(P<0.05)。大黄素对Egr-1无影响。综上所述,大黄素对肝细胞具有保护作用,通过抗炎作用对胆汁淤积性肝炎具有恢复活性。其作用主要归因于拮抗促炎细胞因子和介质、抑制氧化损伤、改善肝微循环、减少损伤信号以及控制中性粒细胞浸润。